in serum; blood testing for anti-CMV IgM, anti-HSV IgG/IgM, VDRL for syphilis, anti-toxoplasma IgG/IgM, HBsAg, and anti-HCV were all negative; CSF for anti-CMV IgM/IgG, anti-HSV IgG/IgM, VDRL, and PCR for TB and CMV were negative.
The patient gradually improved, and a repeat MRI after one month showed marked improvement in the confluent nerve roots [ Figure 1B ]. At three months follow-up, the patient was taken off Gancyclovir, and had recovered >50% of motor, sensory, and bladder and bowel function. He became ambulatory and tendon reflexes normalized. The final clinical impression was that of AIDS-related CMV polyradiculopathy that failed to respond to oral Gancyclovir but responded well to IV Gancyclovir and HAART.
Polyradiculopathy in AIDS is a rare but devastating syndrome. This report, to the best of our knowledge, is the first such report from the Indian subcontinent. The differential diagnosis includes CMV, [1, 2] tuberculosis, Varicella zoster virus, Ebstein Barr virus, Herpes simplex virus, syphilis, and lymphoma. CMV causes a subacute, progressive, asymmetric ascending paraplegia with urinary retention and sacral dysesthesias. Initial CSF examination in CMV may reveal the "classic" pattern of polymorphonuclear pleocytosis, elevated protein, and decreased glucose in only 50%. Nucleic acid amplification techniques are often rapid, sensitive, and specific, though expensive. In our case PCR for CMV was negative in CSF; although this test generally has sensitivity greater than 80%, [3] prior treatment decrease yield. Detection of CMV antigens (pp65) in CSF has a sensitivity of 91% and specificity approaching 100%. [4] Histopathological examination of the cauda equina roots shows polymorphonuclear or mononuclear Treatment is usually empirical with IV Gancyclovir. Foscarnet may be used in rare cases of Gancyclovirresistance. [5] Response to therapy may be assessed by a repeat lumbar puncture after two weeks. Prolonged IV initiation therapy with subsequent oral maintenance may be required. Finally, even if a viral etiology is highly likely, the clinician may choose to initiate ATT, especially in India. All together, three classes of etiological agents may be targeted in the HIV-positive subacute progressive polyradiculopathy patient: HIV, tuberculosis, and the herpesviridae family.
